Peer Review History
| Original SubmissionJanuary 15, 2024 |
|---|
|
PONE-D-23-41748Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study ProtocolPLOS ONE Dear Dr. Deslauriers, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Yaodong Gu Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This work is being conducted as part of the first author’s PhD thesis. She gratefully acknowledges the financial support of the Research Center of the Institut universitaire de santé mentale de Montréal for the writing of this manuscript." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "The first author (TD) is supported by a scholarship from the Canadian Institutes of Health Research (CIHR) grant obtained by the directors (BV, IG) (https://cihr-irsc.gc.ca/, no: 159486). The funders did not and will not have a role in study design, data collection, analysis, decision to publish, or preparation of manuscripts." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. Additional Editor Comments: The main contribution of this study shall be pointed out in the discussion. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Partly Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: No Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Review comment This manuscript entitled “Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol” primarily aimed to present the protocol of a multiple case study that is being conducted to document how this approach was implemented in different large healthcare organizations in Quebec. There are still some problems that cannot up this study to a publishing level. Some suggestions are listed in the specific comments below. Specific comments: 1. What is the relationship between the multiple case study protocol proposed by the authors and the “Framework for the partnership approach between patients, their families and health and social service stakeholders” published by Quebec’s Ministry of Health and Social Services? Please further emphasise. 2. Given the relevance to the framework, is the current protocol limited to implementation in Quebec? I would recommend that the authors clarify this further in the manuscript (e.g., in the discussion section). 3. “Twelve to 15 key respondents will be recruited for each case”, how was the number of subjects determined? 4. Please provide the full name of the abbreviations when they first appear in the manuscript, e.g., here: “non-participant observations of the meetings of the QI committee engaging PFPs and”. The abbreviation “PFP” is not reasonably defined. 5. “This study will provide a better understanding of how healthcare organizations…”, I would suggest that the authors further enhance the discussion in the abstract section as it is unclear and does not provide information on the significant advantages of the current multiple case study protocol. 6. The research objectives proposed by the authors seem to be overstated, for example, “Analyze the adoption, fidelity and penetration of implementation of the partnership approach in QI within healthcare organizations.” 7. In the methods section, lengthy explanations of some basic research concepts (e.g., “case studies” and “case”) are unnecessary; please simplify them further. 8. In the semi-structured individual interviews, what was the basis for developing the relevant questions in the interview guides? 9. “In addition, since the coding step will be performed mainly by the first student-researcher, bimonthly meetings will be held with the research team…”, please provide more details about the data analysis section, especially the steps involving data coding. How was it implemented? 10. In the rigorous design of the case study, “Its credibility will be strengthened by triangulating the data collection methods (interviews, observations, document analysis) and debriefing the members of the research team during data interpretation via bi-weekly meetings”, How can the credibility of this study be enhanced through “bi-weekly meetings”? 11. In the discussion section, the potential contribution on the project needs to be further strengthened. Reviewer #2: Review comment This manuscript entitled “Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol” primarily aimed to explore how the partnership approach with patients and families is implemented in Quebec's healthcare organizations, following the province's guidelines. The results of this study provide guidance for publilc health. While it is a very interesting topic. But I think this manuscript has a lot of flaws to fill in before it can be published in a journal. There are several questions should be addressed, which list below. I give a minor revision for this manuscript. Specific comments 1. In the Summary part, "However, while this framework provides guidelines by describing each partner’s role and the ways in which patient and family partners should be engaged in QI processes, it remains unclear how these recommendations were actually used and implemented by different healthcare organizations." Could you elaborate on the specific gaps or uncertainties in the implementation of the guidelines within healthcare organizations that this study aims to explore? 2. "Patient-centered approaches have emerged in healthcare organizations seeking to move away from paternalistic approaches and encourage more active participation from patients, families, and communities as partners in the healthcare system." What are the theoretical frameworks or models that underpin the transition from paternalistic to patient-centered care in the context of QI processes, and how have these models been evaluated for effectiveness in previous studies? 3. "This qualitative multiple case study will be conducted in four large healthcare organizations in Quebec. Twelve to 15 key respondents will be recruited for each case." What criteria were used to select these healthcare organizations and respondents, and how do these criteria ensure a comprehensive understanding of the patient partnership approach across different organizational contexts? 4. "This study will provide a better understanding of how healthcare organizations successfully engage PFPs in QI processes in different organizational contexts..." Based on preliminary insights or existing literature, what are the anticipated challenges in engaging patient and family partners in QI processes, and how might this study's findings contribute to overcoming these challenges? 5. In the Introduction part, “These include strategic support, the presence of leaders, the presence of formal processes and financial resources.” Please add a reference to support this sentence. 6. “It helps establish the necessary infrastructure and promote a change in attitudes and culture to one that is favorable to patient engagement” Please provide a more detailed description of how to address barriers to patient participation, for example, How to Avoid" No Show" to Planned Appointments? Musa, S., Al Baker, W., Al Muraikhi, H., Nazareno, D., Al Naama, A., & Dergaa, I. (2021). Wellness Program Within Primary Health Care: How to Avoid" No Show" to Planned Appointments? -A Patient-Centred Care Perspective. Physical Activity & Health (2515-2270), 5(1). 7. “For their part, the program departments are responsible for implementing the partnership approach in organizational and clinical practices, including QI.” The reviewer suggested that the author provide a more detailed description of the partnership approach. 8. In the Methods part, “It therefore lends itself well to the study of management practices designed to promote partnerships with patients and their families.” Please add a reference to support this sentence. 9. In the Conclusion part, Please show detailed findings about this manuscript as well as what are the contributions for future clinical or scientific research. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Zixiang Gao ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol PONE-D-23-41748R1 Dear Dr. Deslauriers, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yaodong Gu Academic Editor PLOS ONE Additional Editor Comments (optional): Well done! Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: After careful revision by the authors, this manuscript has been greatly improved and all issues have been addressed. Reviewer #2: Thank you to the authors for their hard work. The reviewers believe that after detailed revisions, this study has reached the level required for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Zixiang Gao ********** |
| Formally Accepted |
|
PONE-D-23-41748R1 PLOS ONE Dear Dr. Deslauriers, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Yaodong Gu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .